Research highlights long-term health effects of hormone therapy in transgender individuals

New research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, particularly in transgender men.

Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product | Psychedelic Invest

Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of

July 20, 2024

BioNTech signs 3D printing deal to develop oral RNA drugs

BioNTech is partnering with a 3D printing company to work on better delivering its RNA-based treatments. The Covid-19 vaccine maker is paying $10 million upfront

July 25, 2024

Pα+ Psychedelic Bulletin #172: Lykos Scales Back IIT Program, CEO Steps Down; Psyence Scoops Up Clairvoyant for Peanuts; Mindstate’s Moxy Enters Phase I – Psychedelic Alpha

In this Issue Lykos Scales Back Investigator-Initiated Trials Program, Refers Some Researchers to PharmAla Lykos Appoints ‘Pharma Veterans’ to C-Suite Psyence Scoops Up Clairvoyant for

September 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.